REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Africure Pharmaceuticals Limited (Mauritius)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Africure Pharmaceuticals Limited Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a manufacturer and distributor of pharmaceutical products and operates throughout Sub-Saharan Africa. The Company's objective is to bring pharmaceutical manufacturing technology into Africa, thereby providing Africans access to generic medicine ataffordable prices.
History:
The Company was incorporated on 17 March 2017 in Mauritius and holds a Global Business License.
The Company s ordinary shares commenced trading on the Official Market of the Stock Exchange of Mauritius Ltd on 7 October 2022.

Headquarters
6Th Floor, Tower A, 1 Cybercity
Ebene; Plaines Wilhems;

Contact Details: Purchase the Africure Pharmaceuticals Limited report to view the information.

Website: http://www.africurepharma.com

Basic Information
Total Employees:
Purchase the Africure Pharmaceuticals Limited report to view the information.
Outstanding Shares:
Purchase the Africure Pharmaceuticals Limited report to view the information.
Financial Auditors:
Purchase the Africure Pharmaceuticals Limited report to view the information.
Incorporation Date:
2017
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Subsidiaries
Africure Pharmaceuticals Ltd. Nigeria (Nigeria)
100%
Africure Pharmaceuticals (India) Private Limited (India)
51%
Company Performance
Financial values in the chart are available after Africure Pharmaceuticals Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-22.8%▼
Total operating revenue
-20.96%▼
Operating profit (EBIT)
-28%▼
EBITDA
-10.9%▼
Net Profit (Loss) for the Period
-95.64%▼
Total assets
0.63%▲
Total equity
12.2%▲
Operating Profit Margin (ROS)
-0.62%▼
Net Profit Margin
-2.78%▼
Return on Equity (ROE)
-4.41%▼
Debt to Equity Ratio
-40.28%▼
Quick Ratio
-0.19%▼
Cash Ratio
-0.12%▼

Similar companies

Ibl Limited
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo